What is the prevalence of Factor VII Deficiency?

Factor VII deficiency is a rare inherited bleeding disorder with an estimated prevalence of approximately 1 in 300,000 to 1 in 500,000 individuals in the general population. While the condition is considered rare, these figures likely underestimate the true prevalence due to many asymptomatic or mildly affected individuals remaining undiagnosed.

What is the prevalence of Factor VII deficiency?

Factor VII deficiency is classified as a rare disease. Epidemiological estimates suggest a prevalence of 1 in 300,000 to 500,000; however, because the clinical severity of Factor VII deficiency varies significantly, many people with mild forms may never seek medical attention. The incidence of symptomatic cases is even lower, as many individuals are only identified following surgery or trauma.

Does Factor VII deficiency affect genders and age groups differently?

Factor VII deficiency affects males and females equally, as the underlying gene (F7) is located on chromosome 13, not on the sex chromosomes. The age of onset can vary widely depending on the severity of the mutation. Severe Factor VII deficiency is often identified in infancy or early childhood due to spontaneous bleeding, while mild cases may not be diagnosed until adulthood during a routine blood test or an invasive medical procedure.

Are there geographic or ethnic variations in Factor VII deficiency?

While Factor VII deficiency is found worldwide, it appears more frequently in populations with higher rates of consanguinity (marriage between close relatives). In such communities, the autosomal recessive trait is more likely to be passed from both parents to their offspring, increasing the occurrence of the disorder. Currently, 40 people with Factor VII deficiency have joined the DiseaseMaps.org community, providing a valuable, real-world perspective on how this condition impacts lives across diverse backgrounds.

Why is accurate data on Factor VII deficiency challenging to collect?

Several factors contribute to the difficulty in determining precise statistics for Factor VII deficiency:

• Asymptomatic presentation: Many patients have low factor levels but experience no abnormal bleeding.


• Underdiagnosis: Mild cases are often overlooked until a major bleeding event occurs.


• Diagnostic variability: Laboratory testing for Factor VII deficiency requires specific assays that may not be standard in all clinical settings.

Next steps

• Consult a hematologist specializing in coagulation disorders for accurate diagnostic testing.


• Join the DiseaseMaps.org community to connect with other patients and share lived experiences.


• Discuss your family medical history with a genetic counselor if you are planning a pregnancy.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician regarding a medical condition.

References

• Orphanet: Factor VII deficiency (ORPHA321)


• NIH Genetic and Rare Diseases (GARD) Information Center


• OMIM (Online Mendelian Inheritance in Man): F7 gene (#227500)


• World Federation of Hemophilia (WFH) guidelines on rare bleeding disorders